Silver Spring, Maryland–(ENEWSPF)–March 25, 2015. The U.S. Food and Drug Administration today expanded the approved use for Eylea (aflibercept) injection to treat diabetic retinopathy in patients with diabetic macular edema.
FDA Approves New Treatment for Diabetic Retinopathy in Patients with Diabetic Macular Edema
More in Health and Fitness:
